Liquid Biopsy for Cancer: How a Blood Test Can Help Guide Treatment

Cancer diagnosis and treatment often require doctors to understand what is happening inside a tumour. Traditionally, obtaining this information may involve a tissue biopsy, where a small sample of the tumour is removed and examined.

Today, another technology is playing an increasingly important role in certain situations: liquid biopsy.

A liquid biopsy can analyse cancer-related material found in body fluids, most commonly blood. It may help doctors identify certain genetic changes, understand how a cancer is responding to treatment, or look for changes that could influence future treatment decisions.

But what exactly is a liquid biopsy, and can a blood test really provide useful information about cancer?

What Is a Liquid Biopsy?

A liquid biopsy is a laboratory test that looks for cancer-related material in a sample of body fluid, usually blood.

Cancer cells can release different substances into the bloodstream. Depending on the test, doctors may look for:

• Circulating tumour DNA (ctDNA)
• Circulating tumour cells (CTCs)
• Specific genetic mutations
• Other cancer-related biological markers

One of the most commonly studied components is circulating tumour DNA, or ctDNA.

When cancer cells die or release genetic material, small fragments of their DNA may enter the bloodstream. Laboratory techniques can analyse some of these fragments and look for particular molecular changes associated with the cancer.

How Does a Liquid Biopsy Work?

The process can be relatively straightforward from the patient’s perspective.

Step 1: Blood Sample Collection

A healthcare professional collects a blood sample, similar to a routine blood test.

Step 2: Laboratory Analysis

The sample is sent to a specialised laboratory.

Advanced laboratory techniques may be used to search for cancer-related DNA or other biomarkers circulating in the blood.

Step 3: Identifying Molecular Changes

Depending on the test, the laboratory may look for specific genetic alterations or analyse a broader panel of cancer-associated genes.

Step 4: Clinical Interpretation

The oncologist reviews the results together with other information, including:

• Cancer type
• Cancer stage
• Pathology results
• Imaging findings
• Previous treatments
• Overall health

The result of a liquid biopsy should therefore be considered as one part of the overall clinical picture.

What Is Circulating Tumour DNA (ctDNA)?

Circulating tumour DNA consists of small pieces of DNA released by cancer cells into the bloodstream.

This DNA may contain some of the same genetic changes found within the tumour.

Analysing ctDNA can sometimes help doctors understand the molecular characteristics of a patient’s cancer without obtaining another tumour tissue sample.

However, not every tumour releases enough DNA into the blood to be detected.

For this reason, a negative liquid biopsy result does not necessarily mean that a particular cancer-related mutation is absent.

In some situations, doctors may still recommend tissue testing.

How Can Liquid Biopsy Be Used in Cancer Care?

Liquid biopsy has several potential applications, although its role varies depending on the type of cancer and the clinical situation.

1. Identifying Certain Genetic Mutations

Some cancers contain genetic alterations that can potentially be targeted with specific medicines.

Liquid biopsy may help detect certain mutations and provide information that doctors can use when considering targeted treatment options.

2. Helping Guide Targeted Therapy

Modern cancer medicines are increasingly designed to target particular molecular features of cancer cells.

If a liquid biopsy identifies a clinically relevant alteration, doctors can determine whether an approved targeted treatment or another appropriate option exists for that particular situation.

Finding a mutation does not automatically mean that a targeted medicine will be suitable.

3. Monitoring Cancer During Treatment

Because blood samples can sometimes be collected more easily than repeated tumour biopsies, liquid biopsy is being studied and used in selected settings to monitor molecular changes during treatment.

Changes in ctDNA levels or characteristics may provide additional information about how the cancer is behaving.

The clinical meaning of these changes depends on the cancer type and the test being used.

4. Detecting Treatment Resistance

Cancer can evolve over time.

A treatment that initially works may eventually become less effective because cancer cells develop additional molecular changes.

In selected cancers, liquid biopsy may help identify resistance-related mutations.

This information may help doctors evaluate whether another treatment strategy should be considered.

5. Supporting Cancer Research

Liquid biopsy is also an important area of cancer research.

Researchers are investigating whether these tests can improve:

• Early cancer detection
• Treatment selection
• Treatment-response monitoring
• Detection of minimal residual disease
• Identification of cancer recurrence

Some applications are already used clinically in specific situations, while others remain under investigation.

Liquid Biopsy vs Tissue Biopsy: What Is the Difference?

Although both tests can provide information about cancer, they are not interchangeable in every situation.

A tissue biopsy remains extremely important for diagnosing many cancers because it allows pathologists to directly examine tumour cells and tissues.

Liquid biopsy generally provides complementary molecular information rather than completely replacing conventional biopsy.

What Are the Potential Benefits of Liquid Biopsy?

For appropriately selected patients, liquid biopsy may offer several advantages.

Minimally Invasive

Most liquid biopsies require a blood sample rather than obtaining tissue directly from a tumour.

Easier to Repeat

Doctors may be able to perform blood-based testing at different stages of treatment when clinically appropriate.

Molecular Information

The test may identify genetic changes that could influence treatment decisions.

Potential Insight Into Cancer Changes

Because cancer can evolve during treatment, repeated molecular testing may sometimes identify new alterations associated with treatment resistance.

However, these advantages depend heavily on the cancer type, disease burden and the specific test.

What Are the Limitations of Liquid Biopsy?

Liquid biopsy is a promising technology, but patients should understand its limitations.

Not Every Cancer Releases Detectable DNA

Some tumours release very little DNA into the bloodstream. This can make certain alterations difficult to detect.

A Negative Result May Not Rule Out a Mutation

If no mutation is found in blood, additional tissue testing may still be appropriate in certain situations.

Not Every Mutation Has a Treatment

Modern testing can identify many genetic alterations, but only some have established treatments.

Results Require Expert Interpretation

Finding a molecular alteration does not automatically establish which treatment a patient should receive.

The oncologist must consider the result alongside clinical evidence, cancer type, stage, previous treatment and the patient’s overall condition.

Which Cancers May Use Liquid Biopsy?

Liquid biopsy may be considered in selected clinical situations involving cancers such as:

• Lung cancer
• Breast cancer
• Colorectal cancer
• Prostate cancer
• Certain blood cancers
• Other advanced solid tumours

Its usefulness varies considerably between cancer types.

Doctors decide whether liquid biopsy is appropriate based on the clinical question and available evidence.

Is Liquid Biopsy Used for Early Cancer Detection?

Researchers are actively studying whether blood-based tests can identify cancer before symptoms develop.

This is an exciting area of research, but cancer screening and cancer diagnosis should not be based on unproven blood tests.

Established screening methods remain important for cancers where screening is recommended.

Patients should discuss appropriate cancer screening with a qualified healthcare professional rather than relying on commercially available tests without medical guidance.

Frequently Asked Questions About Liquid Biopsy

Can a liquid biopsy detect cancer?

Some liquid biopsy tests can detect cancer-related material in blood, but their ability to diagnose or screen for cancer depends on the specific test and clinical situation.

A blood test alone does not necessarily replace imaging, pathology or tissue biopsy.

Is liquid biopsy better than tissue biopsy?

Not necessarily.

The two approaches can provide different types of information. Tissue biopsy remains essential in many situations, while liquid biopsy may provide additional molecular information or be useful when obtaining tissue is difficult.

Is liquid biopsy painful?

The blood collection itself is similar to a routine blood test and usually causes only brief discomfort.

Can liquid biopsy help choose cancer treatment?

In selected cases, yes.

If the test identifies a clinically relevant molecular alteration, the oncologist may consider whether an approved targeted therapy or another evidence-based treatment is appropriate.

Can liquid biopsy tell whether treatment is working?

In some cancers and clinical settings, changes in circulating tumour DNA may provide additional information about treatment response.

However, doctors generally interpret this information alongside scans, laboratory tests, symptoms and other clinical findings.

Conclusion

Liquid biopsy is an important development in precision cancer care.

By analysing cancer-related material circulating in the blood, these tests may help doctors identify certain genetic alterations, evaluate potential targeted treatments and understand how a cancer changes over time.

However, liquid biopsy does not replace every tissue biopsy, imaging test or conventional diagnostic method. Its usefulness depends on the cancer type, the amount of detectable tumour material and the specific clinical question being investigated.

At Galaxy Super Speciality, we believe that clear and reliable information can help patients and families better understand developments in modern cancer treatment.

Always discuss biomarker testing, liquid biopsy and treatment decisions with a qualified oncologist who can evaluate your individual medical circumstances.

Medical Disclaimer: This article is intended for general educational purposes only. It does not replace professional medical advice, diagnosis or treatment.